Cetuximab combined with induction oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer: SWOG 0713

BACKGROUND: Neoadjuvant chemoradiation (NCRT) is standard treatment for locally advanced rectal cancer. Pathologic complete response (pCR) has associated with improved survival. In modern phase III trials of NCRT, pCR ranges from 10–20%. Cetuximab improves response in KRAS wild-type (KRAS-wt) metast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Colorectal Cancer
Main Authors: Leichman, Cynthia Gail, McDonough, Shannon L., Smalley, Stephen R., Billingsley, Kevin G., Lenz, Heinz-Josef, Beldner, Matthew A., Hezel, Aram F., Velasco, Mario R., Guthrie, Katherine A., Blanke, Charles D., Hochster, Howard S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598683/
https://ncbi.nlm.nih.gov/pubmed/29233486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2017.10.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados